Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07676539 · ClinicalTrials.gov registry record · NA

Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS)

A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

Active
Registry status
NA
Development phase
8
Enrollment target

NCT07676539 is a NA study that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07676539, a NA study, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction of the intervention. The main questions it aims to answer are: * Is STRW an acceptable, feasible, and satisfactory intervention for teens/young adults and their caregivers? * Does STRW improve daily living skills (e.g., cooking, laundry, money management) for teens and young adults with epilepsy? This is a nonrandomized pilot trial and all participants who enroll will: * Participate in weekly caregiver/teen dyads ( approximately 60 minutes) focused on improving daily living skills with a trained therapist for 15 weeks. * Participate in weekly caregiver groups (approximately 90 minutes) focused on supporting caregivers in coaching their teens in daily living skills development led by 2 trained therapists for 14 of the 15 intervention weeks. * Complete measures of adaptive functioning (to evaluate daily living skills; parent and teen-report) at the start of the study and post-intervention. Additional measures will also be collected. * Have the option to complete post-intervention interviews to provide feedback on the intervention components.

Interventions

  • BEHAVIORAL Surviving and Thriving in the Real World

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-12-03
Est. Completion 2026-07-01
Phase NA

What the Registry Record Tells You About NCT07676539

The ClinicalTrials.gov registry entry for NCT07676539 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Surviving and Thriving in the Real World is the first listed.

NCT07676539 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07676539 about?

NCT07676539 is a clinical study titled "Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS)". The goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction of the intervention....

What is the current status of trial NCT07676539?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-12-03. Estimated completion is 2026-07-01.

What interventions are being tested in trial NCT07676539?

The interventions under investigation include: Surviving and Thriving in the Real World (BEHAVIORAL).

Who is sponsoring clinical trial NCT07676539?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.